PACS
PACS Group, Inc.·Financial Services
33.75
6.172%(−2.22)
Market ClosedLast Updated: — ET
52W L: $7.5052W H: $43.08
PACS NEWS
zacks.com
2d ago
Wall Street Analysts Believe PACS Group, Inc. (PACS) Could Rally 31.15%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 31.2% in PACS Group, Inc. (PACS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
zacks.com
3d ago
PACS vs. MEDP: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of PACS Group, Inc. (PACS) and Medpace (MEDP). But which of these two companies is the best option for those looking for undervalued stocks?
defenseworld.net
Apr 3
Crewe Advisors LLC Has $82.46 Million Stock Holdings in PACS Group, Inc. $PACS
Crewe Advisors LLC increased its stake in PACS Group, Inc. (NYSE: PACS) by 93.1% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,147,815 shares of the company's stock after purchasing an additional 1,035,747 shares during the quarter. PACS Group comprises about
defenseworld.net
Mar 30
PACS Group, Inc. (NYSE:PACS) Receives $44.40 Average Price Target from Brokerages
PACS Group, Inc. (NYSE: PACS - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six research firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to
zacks.com
Mar 23
PACS or MEDP: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both PACS Group, Inc. (PACS) and Medpace (MEDP). But which of these two stocks is more attractive to value investors?
businesswire.com
Mar 16
PACS Group, Inc. to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 17, 2026
SALT LAKE CITY--(BUSINESS WIRE)--PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced today that it will present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on Tuesday, March 17, 2026. Jason Murray, Chief Executive Officer and Chairman of the Board, and Mark Hancock, Interim Chief Financial Officer and Executive Vice Chairman of the Board.
